The Association Between the Survivin C-31G Polymorphism and Gastric Cancer Risk in a Chinese Population
Authors:
- 21 August 2008
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 54 (5) , 1021-1028
Abstract
Introduction The C-31G polymorphism in the survivin promoter could de-represse the cell-cycle-dependent transcription of the human survivin gene, resulting in overexpression of survivin. This survivin mutation has only been studied on cervical carcinoma. However, no study has ever been conducted to evaluate the effect of the polymorphism on other cancers, including gastric cancer. Methods In this hospital-based, case–control study, we investigated the association between the survivin C-31G polymorphism and risk of gastric cancer in a Chinese population using polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP) protocols. Results No statistically significant association was observed between gastric cancer risk and the variant genotype (GG + GC). However, the variant genotype (GG + GC) was either associated with risk of distal gastric cancer (odds ratios = 0.50, 95% confidence interval = 0.30–0.83) or with risk of well-differentiated tumor (odds ratios = 0.46, 95% confidence interval = 0.22–0.97). Conclusion Our results demonstrate that the survivin C-31G polymorphism may be involved in distal gastric carcinogenesis and tumor differentiation in a Chinese population.Keywords
This publication has 36 references indexed in Scilit:
- Survivin, a cancer target with an emerging role in normal adult tissuesMolecular Cancer Therapeutics, 2006
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Combined Treatment of Ionizing Radiation With Genistein on Cervical Cancer HeLa CellsJournal of Pharmacological Sciences, 2006
- Polymorphism and gastric cancerJournal of Gastroenterology and Hepatology, 2005
- Global Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2005
- Prognostic significance and different properties of survivin splicing variants in gastric cancerCancer Letters, 2004
- Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer.2003
- Survivin study: What is the next wave?Journal of Cellular Physiology, 2003
- Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer.International Journal of Molecular Medicine, 2001
- The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.1999